SCHEMBL6290665

SCHEMBL6290665

Fc1ccc(Oc2cccc(Oc3cccc(Oc4ccc(Oc5cccc(Oc6cccc(Oc7ccc(F)cc7)c6)c5)cc4)c3)c2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.60
ALDH1A1 P00352 2/20 0.60
MEN1 O00255 1/20 0.60
MITF O75030 1/20 0.60
GAA P10253 1/20 0.60
MAPT P10636 1/20 0.60
GFER P55789 1/20 0.60
KMT2A Q03164 1/20 0.60
NLRP1 Q9C000 1/20 0.60
NOD2 Q9HC29 1/20 0.60
FURIN P09958 2/20 0.50
F2 P00734 1/20 0.50
F10 P00742 1/20 0.50
SOS1 Q07889 1/20 0.47
HSPB1 P04792 1/20 0.47
MAOB P27338 2/20 0.46
LTA4H P09960 2/20 0.46
TSHR P16473 1/20 0.46
LOXL2 Q9Y4K0 1/20 0.45
LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6289255 1.00 SMN1; SMN2 (0.60) SMN1; SMN2ALDH1A1MEN1MITFGAA
SCHEMBL6289859 1.00 SMN1; SMN2 (0.60) SMN1; SMN2ALDH1A1MEN1MITFGAA
SCHEMBL6290436 1.00 SMN1; SMN2 (0.60) SMN1; SMN2ALDH1A1MEN1MITFGAA
SCHEMBL6290722 1.00 SMN1; SMN2 (0.60) SMN1; SMN2ALDH1A1MEN1MITFGAA
SCHEMBL4569951 1.00 SMN1; SMN2 (0.60) SMN1; SMN2ALDH1A1MEN1MITFGAA
SCHEMBL7940811 0.91 ALDH1A1 (0.50) SMN1; SMN2ALDH1A1MEN1MITFGAA
SCHEMBL13791508 0.89 SMN1; SMN2 (0.67) SMN1; SMN2ALDH1A1MEN1MITFGAA
SCHEMBL27443501 0.89 MAPT (0.50) SMN1; SMN2ALDH1A1MEN1MITFGAA
SCHEMBL6290729 0.88 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1MEN1MITFGAA
SCHEMBL6293128 0.88 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1MEN1MITFGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6933411-B2 Aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2005-08-23 US disclosed
US-6737503-B2 LOW TEMPERATURE ADHESIVE BONDING MITSUI CHEMICALS, INC. (JP) 2004-05-18 US disclosed
US-20040082754-A1 Novel aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2004-04-29 US disclosed
US-20030092870-A1 Novel aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2003-05-15 US disclosed
EP-1288191-A2 Novel aromatic diamine and polyimide thereof Mitsui Chemicals, Inc. (JP) 2003-03-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092870-A1 Novel aromatic diamine and polyimide thereof DDT, AOC1, H1-4 SMN1; SMN2 2287/4885ALDH1A1 902/4885MEN1 2058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.